Eye Health Academy - Eye Health Academy

Eye Health Academy Hero

Improving Clinical
Decision Making with
Engaging CME, Tools,
& Resources

Improving Clinical
Decision Making with
Engaging CME, Tools,
& Resources

Popular

ILLUMIN-8: Real-World Outcomes with Aflibercept 8 Mg in DME
ILLUMIN-8: Real-World Outcomes with Aflibercept 8 Mg in DME
Eye on Ocular Health
ILLUMIN-8: Real-World Outcomes with Aflibercept 8 Mg in DME
Michael A. Klufas, MD
- Michael A. Klufas, MD
Diagnostic Vitrectomy for Infectious Uveitis
Diagnostic Vitrectomy for Infectious Uveitis
Eye on Ocular Health
Diagnostic Vitrectomy for Infectious Uveitis
Steven Yeh, MD, FASRS
- Steven Yeh, MD, FASRS
What's Next in Uveitis Care?
What's Next in Uveitis Care?
Eye on Ocular Health
What's Next in Uveitis Care?
Steven Yeh, MD, FASRS
- Steven Yeh, MD, FASRS
Seeing the Future of Vitreoretinal Care
Seeing the Future of Vitreoretinal Care
Eye on Ocular Health
Seeing the Future of Vitreoretinal Care
Prethy Rao MD, MPH, FACS
- Prethy Rao MD, MPH, FACS
Applying CAS, EUGOGO, VISA: A Micro Case
Applying CAS, EUGOGO, VISA: A Micro Case
MinuteCE®
Applying CAS, EUGOGO, VISA: A Micro Case
Prem S. Subramanian, MD, PhD; Andrea Lora Kossler, MD, FACS
1.00 program credit
- Prem S. Subramanian, MD, PhD
- Andrea Lora Kossler, MD, FACS
1.00 program credit
Understanding IGF-1R Inhibition: Mechanism & Clinical Implications
Understanding IGF-1R Inhibition: Mechanism & Clinical Implications
MinuteCE®
Understanding IGF-1R Inhibition: Mechanism & Clinical Implications
Prem S. Subramanian, MD, PhD; Andrea Lora Kossler, MD, FACS
1.00 program credit
- Prem S. Subramanian, MD, PhD
- Andrea Lora Kossler, MD, FACS
1.00 program credit
Designing Efficient Clinic Workflows for TED Therapy Access
Designing Efficient Clinic Workflows for TED Therapy Access
MinuteCE®
Designing Efficient Clinic Workflows for TED Therapy Access
Prem S. Subramanian, MD, PhD; Kimberly Cockerham, MD
1.00 program credit
- Prem S. Subramanian, MD, PhD
- Kimberly Cockerham, MD
1.00 program credit
Comparing Trial Designs & Outcomes Across IGF-1R Therapies
Comparing Trial Designs & Outcomes Across IGF-1R Therapies
MinuteCE®
Comparing Trial Designs & Outcomes Across IGF-1R Therapies
Andrea Lora Kossler, MD, FACS; Kimberly Cockerham, MD
1.00 program credit
- Andrea Lora Kossler, MD, FACS
- Kimberly Cockerham, MD
1.00 program credit

Clinical Practice

Why Staging TED Correctly Matters Even When CAS Is Low
Why Staging TED Correctly Matters Even When CAS Is Low
MinuteCE®
Why Staging TED Correctly Matters Even When CAS Is Low
Andrea Lora Kossler, MD, FACS; Kimberly Cockerham, MD
1.00 program credit
- Andrea Lora Kossler, MD, FACS
- Kimberly Cockerham, MD
1.00 program credit
MinuteCE®
Severity Matters: Aligning Thyroid Eye Disease Assessment With Modern Therapeutic Advances
Prem S. Subramanian, MD, PhD; Andrea Lora Kossler, MD, FACS
1.00 credit 8 episodes
- Prem S. Subramanian, MD, PhD
- Andrea Lora Kossler, MD, FACS
- Kimberly Cockerham, MD
1.00 credit 8 episodes
Overcoming Real-World Barriers to TED Treatment 
Overcoming Real-World Barriers to TED Treatment 
MinuteCE®
Overcoming Real-World Barriers to TED Treatment 
Prem S. Subramanian, MD, PhD; Andrea Lora Kossler, MD, FACS
1.00 program credit
- Prem S. Subramanian, MD, PhD
- Andrea Lora Kossler, MD, FACS
1.00 program credit
Beyond IGF-1R: IL-6R Inhibition and Future Sequencing
Beyond IGF-1R: IL-6R Inhibition and Future Sequencing
MinuteCE®
Beyond IGF-1R: IL-6R Inhibition and Future Sequencing
Prem S. Subramanian, MD, PhD; Kimberly Cockerham, MD
1.00 program credit
- Prem S. Subramanian, MD, PhD
- Kimberly Cockerham, MD
1.00 program credit
Observation vs. Vitrectomy for Floaters
Observation vs. Vitrectomy for Floaters
Ophthalmology
Observation vs. Vitrectomy for Floaters
Kyle Davis Kovacs, MD; Matthew Starr, MD
- Kyle Davis Kovacs, MD
- Matthew Starr, MD
- Nita Valikodath, MD, MS
Managing RVO: Goals of Early Intervention
Managing RVO: Goals of Early Intervention
Eye on Ocular Health
Managing RVO: Goals of Early Intervention
Michael Javaheri, MD, MSc, FASRS
- Michael Javaheri, MD, MSc, FASRS
Choosing the Right Therapy for RVO Patients
Choosing the Right Therapy for RVO Patients
Eye on Ocular Health
Choosing the Right Therapy for RVO Patients
Michael Javaheri, MD, MSc, FASRS
- Michael Javaheri, MD, MSc, FASRS
Faricimab vs. Aflibercept for Retinal Vein Occlusion
Faricimab vs. Aflibercept for Retinal Vein Occlusion
Eye on Ocular Health
Faricimab vs. Aflibercept for Retinal Vein Occlusion
Michael Javaheri, MD, MSc, FASRS
- Michael Javaheri, MD, MSc, FASRS